The effect of monotherapy with ciprofibrate and in combination with acetylsalicylic acid on the spectrum of lipids, thromboxane and fibrinogen in patients with atherosclerosis and hyperlipoproteinemia;Vplyv ciprofibrátu v monoterapii a v kombinácii s acetylosalicylovou kyselinou na spektrum lipidov, tromboxán a fibrinogén u pacientov s manifestnou aterosklerózou a hyperlipoproteinémiou.

Bratislavské lekárske listy

Volumn 100, Issue 8, 1999, Pages 449-453

  Gajdos, M ^a   Fedelesova, V ^a   Mongiellova, V ^a   Cibulova, L ^a   Huttova, D ^a   Polak, F ^a   Krivosikova, Z ^a  

^a INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; CIPROFIBRATE; CLOFIBRIC ACID; DRUG DERIVATIVE; FIBRINOGEN; LIPID; THROMBOXANE B2;

AGED; ARTERIOSCLEROSIS; ARTICLE; BLOOD; COMPARATIVE STUDY; DRUG COMBINATION; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA; MALE; MIDDLE AGED;

AGED; ANTILIPEMIC AGENTS; ARTERIOSCLEROSIS; ASPIRIN; CLOFIBRIC ACID; DRUG THERAPY, COMBINATION; FEMALE; FIBRINOGEN; HUMANS; HYPERLIPOPROTEINEMIAS; LIPIDS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; THROMBOXANE B2;

EID: 0033169755     PISSN: 00069248     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)